FRA:AFX • DE0005313704
Past quarterly earnings results for CARL ZEISS MEDITEC AG - BR (AFX.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 0.03 | 0.25 | -88.15% | -83.33% | 467M | 489.02M | -4.50% | -4.79% |
| Q4 2025 | 0.59 | 0.65 | -9.05% | -14.49% | 627.545M | 609.76M | 2.92% | 8.27% |
| Q3 2025 | 0.32 | 0.48 | -33.88% | -15.79% | 549.631M | 555.99M | -1.14% | 1.92% |
| Q2 2025 | 0.52 | 0.46 | 13.25% | - | 560.016M | 539.7M | 3.76% | 18.62% |
| Q1 2025 | 0.18 | 0.28 | -36.67% | -57.14% | 490.5M | 486.5M | 0.82% | 3.26% |
| Q4 2024 | 0.69 | 0.50 | 37.18% | -28.13% | 579.627M | 593.86M | -2.40% | -0.01% |
| Q3 2024 | 0.38 | 0.59 | -35.88% | -63.11% | 539.3M | 538.65M | 0.12% | 0.78% |
| Q2 2024 | 0.52 | 0.48 | 8.55% | -24.64% | 472.125M | 509.59M | -7.35% | -6.36% |
| Q1 2024 | 0.42 | 0.33 | 27.56% | - | 475M | 471.63M | 0.71% | 1.01% |
| Q4 2023 | 0.96 | 0.73 | 30.80% | -16.52% | 579.661M | 587.12M | -1.27% | 1.71% |
| Q3 2023 | 1.03 | 0.82 | 26.32% | 47.14% | 535.121M | 533.98M | 0.21% | 12.07% |
| Q2 2023 | 0.69 | 0.74 | -7.37% | -32.35% | 504.218M | 511.62M | -1.45% | 13.25% |
| Q1 2023 | - | - | 470.261M | - | 14.65% | |||
| Q4 2022 | 1.15 | 0.89 | 29.31% | 91.67% | 569.936M | 511.05M | 11.52% | 27.05% |
| Q3 2022 | 0.70 | 0.76 | -7.90% | -23.91% | 477.495M | 485.85M | -1.72% | 10.83% |
| Q2 2022 | 1.02 | 0.70 | 45.45% | 67.21% | 445.229M | 440.37M | 1.10% | 11.74% |
| Q1 2022 | 0.42 | 0.55 | -23.70% | -19.23% | 410.176M | 389.3M | 5.36% | 11.19% |
| Q4 2021 | 0.60 | 0.69 | -13.28% | - | 448.585M | 491.77M | -8.78% | -27.71% |
| Q3 2021 | 0.92 | 0.64 | 44.24% | 1,433.33% | 430.834M | 394.74M | 9.14% | 70.31% |
| Q2 2021 | 0.61 | 0.55 | 10.08% | 117.86% | 398.456M | 394.77M | 0.93% | -44.27% |
| Q1 2021 | 0.52 | 0.37 | 39.15% | 20.93% | 368.9M | 331.75M | 11.20% | -0.22% |
| Q4 2020 | 0.60 | 0.33 | 83.64% | - | 620.526M | 334.89M | 85.29% | - |
| Q3 2020 | 0.06 | - | - | 252.974M | - | - | ||
| Q2 2020 | 0.28 | - | - | 714.926M | - | - | ||
| Q1 2020 | 0.43 | - | - | 369.7M | - | - |
Notes
CARL ZEISS MEDITEC AG - BR (AFX.DE) last reported earnings on 2/12/2026.
CARL ZEISS MEDITEC AG - BR (AFX.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, CARL ZEISS MEDITEC AG - BR (AFX.DE) has beaten EPS estimates in 1 out of 4 releases.